Andreas Bohrer will be responsible for legal, compliance and intellectual property at pharma supplier Lonza.
Andreas Bohrer, Novartis’s animal health division general counsel, has joined pharmaceuticals supplier Lonza as group general counsel and company secretary, where he will be in responsible for legal, compliance and intellectual property. This announcement comes on the heels of Novartis selling its animal health division to fellow pharma giant Eli Lilly on January 1, 2015 in a deal to enhance the company’s animal health business Elanco.
Bohrer joins Lonza having spent five years at Novartis, where he was head of legal transactions. Bohrer became General Counsel of Novartis’s animal health division in 2014 where he was in charge of a team focusing on legal, compliance and IP issues.
Previously, among other roles, Bohrer served as general counsel for investment banking company UBS’ Switzerland operations for a year, was an associate at Zurich-based Lenz & Staehelin for four years, and was a foreign associate at Covington & Burling.
Bohrer told The Lawyer: “Now I am the group general counsel of a company which also has a dual listing, in Singapore. It adds an additional layer of complexity to my work.
“I am in the position to inherit a great team in a diverse place.”
Bohrer will manage a team of around 40 people worldwide, distributed across intellectual property, compliance and legal. The team is based around in the US, Basel and in other locations worldwide including China.
